Botox in pregnancy and during breastfeeding

Botox® (botulinum toxin type A), serves various medical purposes, including the treatment of conditions like migraine headaches, excessive sweating, muscle spasms or stiffness, eye muscle disorders, and urinary incontinence. Additionally, it is used for cosmetic purposes to diminish the appearance of wrinkles, often administered via injections into the skin or muscle.

To date, no studies have investigated whether Botox® increases the risk of miscarriage. Because it is unlikely to enter the bloodstream significantly, its use is unlikely to increase the likelihood of miscarriage during pregnancy.

There is a lack of published research on the use of Botox® during pregnancy. However, a manufacturer's report that covered 137 pregnancies exposed to the substance either during pregnancy or in the months leading up to conception did not identify any discernible pattern of birth defects or an increased risk of birth defects.

Regarding breastfeeding, no studies have been performed. However, given that Botox® injections are not expected to substantially enter the bloodstream, it is improbable that it would be transmitted to breast milk.